Active Ingredient(s): Certolizumab Pegol
FDA Approved: * April 22, 2008
Pharm Company: * UCB INC
Category: Gastrointestinal

Certolizumab pegol, sold under the brand name Cimzia, is a biologic medication for the treatment of Crohn's disease,[1][2] rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha (TNF-α) and is manufactured by UCB.[3][4][5] It is on the World Health Organization's List of Essential Medicines.[6] Co... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Cimzia Kit
NDC: 50474-700
Ucb, Inc.
Cimzia 200 mg/ml Subcutaneous Injection, Solution
NDC: 50474-710
Ucb, Inc.